| Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas JCM Rwigema, SD Parikh, DE Heron, M Howell, H Zeh, AJ Moser, ... American journal of clinical oncology 34 (1), 63-69, 2011 | 189 | 2011 |
| Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study DE Heron, JCM Rwigema, MK Gibson, SA Burton, AE Quinn, RL Ferris American journal of clinical oncology 34 (2), 165-172, 2011 | 130 | 2011 |
| The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body … JCM Rwigema, DE Heron, RL Ferris, RS Andrade, MK Gibson, Y Yang, ... American journal of clinical oncology 34 (4), 372-379, 2011 | 125 | 2011 |
| Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh … JC Rwigema, DE Heron, RL Ferris, M Gibson, A Quinn, Y Yang, ... American journal of clinical oncology 33 (3), 286-293, 2010 | 101 | 2010 |
| Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation V Verma, JCM Rwigema, RS Malyapa, WF Regine, CB Simone II Radiotherapy and Oncology 125 (1), 21-30, 2017 | 93 | 2017 |
| Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators JCM Rwigema, B Beck, W Wang, A Doemling, MW Epperly, D Shields, ... International Journal of Radiation Oncology* Biology* Physics 80 (3), 860-868, 2011 | 91 | 2011 |
| 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity JCM Rwigema, D Nguyen, DE Heron, AM Chen, P Lee, PC Wang, ... International Journal of Radiation Oncology* Biology* Physics 91 (2), 401-409, 2015 | 87 | 2015 |
| Fractionated stereotactic radiosurgery for large brain metastases RE Wegner, JE Leeman, P Kabolizadeh, JC Rwigema, AH Mintz, ... American journal of clinical oncology 38 (2), 135-139, 2015 | 79 | 2015 |
| Cost-comparativeness of proton versus photon therapy V Verma, C Shah, JCM Rwigema, T Solberg, X Zhu, CB Simone II Chinese clinical oncology 5 (4), 56-56, 2016 | 68 | 2016 |
| Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins JCM Rwigema, DE Heron, SD Parikh, HJ Zeh, JA Moser, N Bahary, ... Journal of gastrointestinal cancer 43, 70-76, 2012 | 67 | 2012 |
| Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy D Nguyen, JCM Rwigema, VY Yu, T Kaprealian, P Kupelian, M Selch, ... Radiation Oncology 9, 1-9, 2014 | 62 | 2014 |
| Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration … JA Vargo, DE Heron, RL Ferris, JCM Rwigema, R Kalash, RE Wegner, ... Head & neck 36 (9), 1349-1355, 2014 | 59 | 2014 |
| Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck JA Vargo, RE Wegner, DE Heron, RL Ferris, JCM Rwigema, A Quinn, ... Head & neck 34 (8), 1153-1161, 2012 | 59 | 2012 |
| Prospective study of proton‐beam radiation therapy for limited‐stage small cell lung cancer JCM Rwigema, V Verma, L Lin, AT Berman, WP Levin, TL Evans, ... Cancer 123 (21), 4244-4251, 2017 | 56 | 2017 |
| A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator–based stereotactic body radiotherapy for central early-stage non− small cell … C Merna, JCM Rwigema, M Cao, PC Wang, AU Kishan, A Michailian, ... Medical Dosimetry 41 (1), 87-91, 2016 | 53 | 2016 |
| Prospective evaluation of patient-reported quality-of-life outcomes following SBRT±cetuximab for locally-recurrent, previously-irradiated head and neck cancer JA Vargo, DE Heron, RL Ferris, JCM Rwigema, RE Wegner, R Kalash, ... Radiotherapy and Oncology 104 (1), 91-95, 2012 | 52 | 2012 |
| Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis MW Epperly, JP Goff, S Li, X Gao, P Wipf, T Dixon, H Wang, D Franicola, ... in vivo 24 (6), 811-819, 2010 | 51 | 2010 |
| Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation K Wang, DE Heron, DA Clump, JC Flickinger, GJ Kubicek, JCM Rwigema, ... Radiotherapy and Oncology 106 (1), 90-95, 2013 | 48 | 2013 |
| Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults ME Gamez, R Kraus, ML Hinni, EJ Moore, DJ Ma, SJ Ko, JCM Rwigema, ... Oral oncology 87, 43-48, 2018 | 47 | 2018 |
| A model-based approach to predict short-term toxicity benefits with proton therapy for oropharyngeal cancer JCM Rwigema, JA Langendijk, HP van der Laan, JN Lukens, ... International Journal of Radiation Oncology* Biology* Physics 104 (3), 553-562, 2019 | 45 | 2019 |
Percy Lee, M.D.Professor and Vice~Chair, Medical Director of OC and Coastal Radiation Oncology, City of Hope在 coh.org 的电子邮件经过验证
